Regeneron says its antibody cocktail likely weakened by Omicron variant
Sources of information influence COVID-19 knowledge, protective behaviors
30 November 2021Irregular heartbeat risk linked to frequent alcohol use in people under 40
30 November 2021Regeneron says its antibody cocktail likely weakened by Omicron variant
(HealthDay)—Regeneron Pharmaceuticals said Tuesday that its antibody cocktail, which is used widely to treat COVID-19 patients, may be less effective against the Omicron variant.
